Ji Hyeon Im

Ms. Ji Hyeon Im

Seoul National University, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YSYern-Hyerk Shin
Yern-Hyerk Shin
JIJi Hyeon Im
Ji Hyeon Im
IKIlnam Kang
Ilnam Kang
EKEunji Kim
Eunji Kim
SJSung Chul Jang
Sung Chul Jang
DODong-Chan Oh
Dong-Chan Oh

16 March 2022 in Journal of Natural Products
Verified
Journal Article
Closed access
JAJoon Soo An
Joon Soo An
MKMyoun-Su Kim
Myoun-Su Kim
JHJaeho Han
Jaeho Han
SJSung Chul Jang
Sung Chul Jang
JIJi Hyeon Im
Ji Hyeon Im
DODong-Chan Oh
Dong-Chan Oh

27 September 2022 in Organic Letters
Verified
Journal Article
Closed access
JIJi Hyeon Im
Ji Hyeon Im
DSDaniel Shin
Daniel Shin
YBYeon Hee Ban
Yeon Hee Ban
WBWoong Sub Byun
Woong Sub Byun
EBEun Seo Bae
Eun Seo Bae
DODong-Chan Oh
Dong-Chan Oh

18 July 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JIJi Hyeon Im
Ji Hyeon Im
YSYern-Hyerk Shin
Yern-Hyerk Shin
EBEun Seo Bae
Eun Seo Bae
SLSang Kook Lee
Sang Kook Lee
DODong-Chan Oh
Dong-Chan Oh
Four new chlorinated cycloaromatized enediyne compounds, jejucarbosides B–E (1–4), were discovered together with previously-identified jejucarboside A from a marine actinomycete strain. Compounds 1–4 were identified as new chlorinated cyclopenta[a]indene glycosides based on 1D and 2D nuclear magnetic resonance, high-resolution mass spectrometry, and circular dichroism (CD) spectra. Jejucarbosides B and E bear a carbonate functional group whereas jejucarbosides C and D are variants possessing 1,2-diol by losing the carbonate functionality. It is proposed that the production of 1–4 occurs via Bergman cycloaromatization capturing Cl- and H+ in the alternative positions of a p-benzyne intermediate derived from a 9-membered enediyne core. Jejucarboside E (4) displayed significant cytotoxicity against human cancer cell lines including SNU-638, SK-HEP-1, A549, HCT116, and MDA-MB-231, with IC50 values of 0.31, 0.40, 0.25, 0.29, and 0.48 μM, respectively, while jejucarbosides B–D (1–3) showed moderate or no cytotoxic effects.